Form 4 holding
PRESIDENT, Director
PROVECTUS BIOPHARMACEUTICALS, INC.
- Security class
- Stock Options (Right to Buy)
- Shares / value
- 16,146,600
- Estimated value
- Report date
- 02 Dec 2024
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount